U.S. Other Utilities Stock News

NYSE:OFG
NYSE:OFGBanks

Assessing OFG Bancorp (OFG) Valuation After Q1 Beat And Digital First Progress

Q1 results and digital-first push in focus for OFG Bancorp (OFG) OFG Bancorp (OFG) has been in focus after first quarter results topped Wall Street expectations, with management pointing to ongoing loan growth, steady credit performance, and disciplined expense management. See our latest analysis for OFG Bancorp. The share price has gained 11.3% over the past month and 13.5% over the past quarter. The 1 year total shareholder return of 13.8% and 3 year total shareholder return, which is about...
NasdaqGS:BYND
NasdaqGS:BYNDFood

Is Beyond Meat’s (BYND) Army Ration Interest Quietly Reshaping Its Risk Profile And Brand Story?

Beyond Meat recently expanded its retail footprint by rolling out Beyond Chicken Pieces Spicy Buffalo to more than 2,000 Kroger stores across the U.S., while the U.S. Army signaled interest in plant-based proteins for future field rations. These developments highlight how product innovation and potential government demand could interact with Beyond Meat’s existing efforts to refine its portfolio and operations. We’ll now examine how the U.S. Army’s interest in plant-based protein could...
NYSE:RRC
NYSE:RRCOil and Gas

How Q1 2026 Earnings Strength and Vanguard’s Stake At Range Resources (RRC) Has Changed Its Investment Story

In April 2026, Range Resources reported first-quarter 2026 results showing daily production of about 1,508,842 Mcf of natural gas, 108,193 barrels of NGLs, 8,239 barrels of oil and total revenue of US$1,034.17 million, with net income of US$341.63 million and diluted EPS of US$1.44 from continuing operations. Alongside these stronger operational and financial results, new Schedule 13G filings reveal that Vanguard entities have built passive stakes above 5% of Range Resources’ outstanding...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Mining (HL) Valuation Check After Strong EPS Surge And Revenue Growth Spurs Investor Interest

Operational momentum behind recent price move Hecla Mining (HL) recently drew investor attention after a very large year over year jump in earnings per share and a 79.5% rise in quarterly revenue, alongside higher next quarter EPS estimates. See our latest analysis for Hecla Mining. Despite the latest 0.22% 1-day share price return and recent short-term weakness, Hecla Mining’s very large 1-year total shareholder return of 298.47% signals that momentum has been building over a longer...
NYSE:PRM
NYSE:PRMChemicals

Evaluating Perimeter Solutions (PRM) After Analyst Upgrades And Strong Momentum-Driven Repricing

Recent analyst upgrades and favorable momentum scores have put Perimeter Solutions (PRM) back on many watchlists, with positive earnings estimate revisions and strong industry relative share performance drawing fresh attention from investors. See our latest analysis for Perimeter Solutions. The recent 17.74% 1 month share price return, together with a very large 1 year total shareholder return of around 3x, suggests momentum is building as investors reassess Perimeter Solutions at a last...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

How Investors Are Reacting To CleanSpark (CLSK) Using Bitcoin Mining Cash To Build AI-Ready Data Centers

In recent months, CleanSpark reported rapid growth in Bitcoin mining output, expanded its hashrate to 50 EH/s, and closed the acquisition of a second Texas data center campus adding 300 megawatts of power capacity to support both mining and AI or cloud workloads. An interesting angle for investors is how CleanSpark is using cash flow from Bitcoin mining to build a Bitcoin treasury while reinvesting into power-heavy data center infrastructure that can serve high-performance computing demand...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Pipeline Wins And Dividend Hike Might Change The Case For Investing In Johnson & Johnson (JNJ)

In late April 2026, Johnson & Johnson reported strong first‑quarter results with revenue of US$24.06 billion, raised its full‑year sales outlook to US$100.30–US$101.30 billion, increased its quarterly dividend to US$1.34 per share, and advanced key therapies including IMAAVY (nipocalimab) receiving FDA Priority Review in warm autoimmune hemolytic anemia and CAPLYTA (lumateperone) gaining an expanded label for preventing schizophrenia relapse. These moves highlight Johnson & Johnson’s effort...
NYSE:NJR
NYSE:NJRGas Utilities

Is It Too Late To Consider New Jersey Resources (NJR) After Its Strong Multi Year Run?

If you are wondering whether New Jersey Resources at around US$56 is offering good value today, it helps to step back and look at what the recent price and fundamentals are really telling you. The stock has recently closed at US$56, with returns of 0.3% over 7 days, 1.8% over 30 days, 21.8% year to date, 17.6% over 1 year, 23.4% over 3 years, and 54.5% over 5 years. This gives plenty of data points to weigh up how the market currently views its prospects and risks. Recent coverage around New...
NYSE:HLIO
NYSE:HLIOMachinery

Helios Technologies (HLIO) Valuation Check After Recent Share Price Softness

Context for Helios Technologies after recent performance Helios Technologies (HLIO) has drawn renewed investor interest after a recent period where the stock showed mixed moves, with a 2.3% decline over the past week and a 2.2% decline over the past month. See our latest analysis for Helios Technologies. Despite the recent soft patch in the share price, with a 30 day share price return of a 2.18% decline, momentum over a longer window still reflects a 22.17% year to date share price gain and...
NYSE:CRI
NYSE:CRILuxury

A Look At Carters (CRI) Valuation After Recent Share Price Weakness

Recent performance snapshot Carter's (CRI) has drawn attention after recent share price moves, with the stock down about 7% over the past week and roughly 5% over the past month, compared with a smaller 3% decline over the past 3 months. See our latest analysis for Carter's. With the share price at $33.71, Carter's recent 1 day share price return of a 6.67% decline and 7 day return of a 9.38% decline sit against a relatively modest 1 year total shareholder return of a 0.34% decline and a much...
NYSE:NFG
NYSE:NFGGas Utilities

A Look At National Fuel Gas (NFG) Valuation As Long Term Returns Contrast With Recent Weakness

National Fuel Gas (NFG) has recently drawn investor attention after its share price closed at $82.98, with recent returns showing mixed moves over the past week, month, and past 3 months. Investors may now reassess its fundamentals. See our latest analysis for National Fuel Gas. The recent 1 day share price return of negative 1.66% extends a short term pullback, with the 30 day share price return of negative 10.65% contrasting with a 5 year total shareholder return of 84.62%. This suggests...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

FDA Priority Review For New HIV Combo Might Change The Case For Investing In Gilead Sciences (GILD)

Gilead Sciences, Inc. recently announced that the FDA accepted its New Drug Application for an investigational once-daily single-tablet HIV regimen combining bictegravir 75 mg and lenacapavir 50 mg for virologically suppressed adults, granting priority review with a PDUFA action date of August 27, 2026, based on positive Phase 3 ARTISTRY-1 and ARTISTRY-2 data. The filing underscores Gilead’s efforts to refresh its core HIV portfolio with a compact regimen that maintained virological...
NasdaqGS:CBSH
NasdaqGS:CBSHBanks

Commerce Bancshares (CBSH) Valuation Check After FineMark Integration Costs And Analyst Downgrades

Commerce Bancshares (CBSH) is under scrutiny after missing first quarter revenue expectations and reporting higher than expected integration costs tied to its FineMark Holdings acquisition, with insider selling and cautious analyst commentary adding further pressure. See our latest analysis for Commerce Bancshares. Over the past year, Commerce Bancshares’ share price has been under pressure, with short term momentum soft despite a 5.58% 1 month share price return and a 1 year total...
NYSE:BKV
NYSE:BKVOil and Gas

A Look At BKV (BKV) Valuation After Hedge Fund Entry And Anticipation Of 2026 Earnings

Recent moves in BKV (BKV) stock come as investors weigh two catalysts: the upcoming May 7, 2026 earnings release, which is expected to show lower earnings on higher revenue, and fresh interest from a prominent hedge fund. See our latest analysis for BKV. At a share price of $31.32, BKV has seen a 14.98% 1 month share price return and a 68.39% 1 year total shareholder return, suggesting momentum has picked up as investors focus on the upcoming earnings update and hedge fund interest. If you...
NYSE:GVA
NYSE:GVAConstruction

A Look At Granite Construction (GVA) Valuation As Raised 2026 Guidance Follows Strong Q1 Results

Granite Construction (GVA) is back in focus after Q1 2026 results showed stronger than expected revenue, a higher full year revenue outlook to US$5.2b to US$5.4b, and record backlog supported by acquisitions. See our latest analysis for Granite Construction. The stronger Q1 2026 update appears to have fed into the share price, with Granite Construction’s 7 day share price return of 13.01% and 30 day return of 13.98% adding to a 1 year total shareholder return of 72.64%. This suggests momentum...
NYSE:GPOR
NYSE:GPOROil and Gas

A Look At Gulfport Energy’s (GPOR) Valuation As Earnings, Buybacks And Leadership Changes Draw Focus

Anticipation around Gulfport Energy (GPOR) is building as investors look toward the upcoming March quarter earnings report, which is expected to feature higher year over year earnings and revenue, along with continued share repurchases and leadership changes. See our latest analysis for Gulfport Energy. At a share price of US$189.90, Gulfport Energy has seen a 1 day share price return of a 1.4% decline and a 30 day share price return of a 9.4% decline, while its 3 year total shareholder...
NYSE:CALY
NYSE:CALYLeisure

Is It Too Late To Reassess Callaway Golf (CALY) After Its Recent Share Price Surge

If you are wondering whether Callaway Golf at around US$15.16 is still reasonably priced after its recent run, the valuation story is the key place to focus. The stock has seen sharp moves, with a 29.4% return year to date and 121.3% over the last year, set against a 32.1% decline over three years and a 51.3% decline over five years. These swings have kept Callaway Golf on many watchlists, as investors weigh shorter term momentum of 9.7% over the last 30 days against a 1% decline over the...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

A Look At Berkshire Hathaway’s Valuation As Shares Trade Below An Estimated Fair Value

Recent performance and business snapshot Berkshire Hathaway (BRK.A) has drawn investor attention after recent trading, with the share price closing at US$710,300 and short term returns mixed across the past week and month. Over the past 3 months, Berkshire Hathaway has recorded a total return of about 1.7% decline and about 4.5% decline year to date, while the 1 year total return shows about 12.2% decline. Longer term figures are different, with 3 year and 5 year total returns of 44.4% and...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

Is Match Group (MTCH) Quietly Recasting Its Moat Around Ultra-Niche LGBTQ Dating Communities?

In late April 2026, Match Group announced a US$100,000,000 minority investment in Sniffies, a real-time map-based cruising app for queer men, with an option to fully acquire the platform while keeping it founder-led and operationally independent. This move, alongside ongoing efforts to court LGBTQ users after acquiring Her, indicates Match Group is broadening its portfolio toward more niche, community-focused dating and social experiences. We’ll now explore how Match Group’s US$100,000,000...
NYSE:EE
NYSE:EEOil and Gas

Excelerate Energy (EE) Valuation Check As Investors Weigh LNG Growth Story Against Premium P/E Multiple

Without a specific news headline driving Excelerate Energy (EE) today, investors are focusing on the stock’s recent returns, its value score of 3, and the company’s role in global liquefied natural gas infrastructure. See our latest analysis for Excelerate Energy. At a share price of $34.47, Excelerate Energy’s recent 30-day share price return of 7.15% contrasts with a 90-day share price return decline of 7.71%. The 1-year total shareholder return of 35.40% and 3-year total shareholder return...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Raised 2026 Guidance And Leadership Change Might Change The Case For Investing In Medpace (MEDP)

In April 2026, Medpace Holdings reported first-quarter 2026 results showing sales of US$706.6 million and net income of US$123.87 million, with both basic and diluted earnings per share rising year over year, and issued full-year 2026 guidance for revenue of US$2.76–2.86 billion and GAAP net income of US$487.0–511.0 million alongside President Jesse Geiger’s planned retirement. An interesting detail for investors is that Medpace’s full-year 2026 outlook assumes a 19–20% tax rate and US$27.5...
NYSE:FIHL
NYSE:FIHLInsurance

Fidelis Buyback And Bye Law Changes Reframe Capital Return Outlook

Fidelis Insurance Holdings (NYSE:FIHL) has entered into a major share repurchase agreement that ends founding shareholder CVC Falcon Holdings Limited's ownership stake. The company has also approved amendments to its Bye Laws at its latest annual meeting, signaling changes to its governance framework. These decisions mark a meaningful shift in ownership and corporate rules that is relevant for existing and prospective shareholders. Fidelis Insurance Holdings, a specialty insurance and...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Is It Too Late To Consider Incyte (INCY) After A 55% One Year Rally?

If you are wondering whether Incyte's current share price still offers value or has already priced in recent enthusiasm, the next sections will walk through what the numbers actually say. Over the past year the stock has returned 55.0%, with shorter term moves of 2.4% over 7 days, 2.8% over 30 days and a year to date return of a 4.4% decline, which can change how the market views both its growth potential and its risks. Recent coverage has focused on Incyte's position in biotech and the...
NYSE:HUN
NYSE:HUNChemicals

Huntsman Q1 Loss Of US$0.30 Per Share Tests Bullish Margin Recovery Narratives

Huntsman (HUN) opened 2026 with Q1 revenue of US$1.4 billion and a basic EPS loss of US$0.30, while the trailing twelve months show revenue of US$5.7 billion and a basic EPS loss of US$1.87. Over recent quarters, revenue has ranged between US$1.4 billion and US$1.5 billion, with quarterly basic EPS losses stretching from roughly US$0.02 to US$0.92. Investors are therefore looking at a business that is still working through margin pressure rather than expanding profitability. See our full...